<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140582" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Fructose Metabolism</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dholariya</surname>
            <given-names>Sagar J.</given-names>
          </name>
          <aff>AIIMS, Rajkot</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Orrick</surname>
            <given-names>Josephine A.</given-names>
          </name>
          <aff>Boston University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sagar Dholariya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Josephine Orrick declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140582.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Fructose is an abundant monosaccharide in the human diet that the body needs to metabolize. It is present in honey, fruits, vegetables, and high-fructose corn syrup used to manufacture beverages (soft drinks) and food. Their consumption results in a significant amount of added sugars entering the diet, approximately half of which is fructose. Sucrose (table sugar) converts to fructose and glucose by acid hydrolysis in the stomach and sucrase-isomaltase cleavage in the small intestine.<xref ref-type="bibr" rid="article-140582.r1">[1]</xref></p>
        <p>Transport and metabolism of fructose do not require insulin; only a few tissues, such as the liver, intestine, kidney, adipose tissue, and muscle, can metabolize it (see<bold> Image.</bold> The Metabolic Pathway of Fructose). Glucose and fructose have similar metabolic fates because most dietary fructose converts into glucose.<xref ref-type="bibr" rid="article-140582.r2">[2]</xref> The mechanism of fructose sensing helps to understand the metabolism and potential pathophysiological consequences of excessive sugar intake.</p>
      </sec>
      <sec id="article-140582.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>The metabolism of dietary fructose to yield energy is known as fructolysis. The process of fructolysis utilizes most of the same enzymes and metabolic intermediates as the glycolysis pathway. However, unlike glucose, which metabolizes directly throughout the body, fructose metabolizes predominantly in the liver. It directs toward the replenishment of liver glycogen and the synthesis of triglycerides.<xref ref-type="bibr" rid="article-140582.r3">[3]</xref><xref ref-type="bibr" rid="article-140582.r4">[4]</xref></p>
        <p>As a result, fructose metabolism produces the same ATP as glucose. However, fructose enters glycolysis without going through the energy investment step; as a result, it yields one extra&#x000a0;adenosine triphosphate (ATP). There are&#x000a0;2 pathways to metabolize fructose. The hexokinase in muscle and adipose tissue phosphorylates fructose, which then enters glycolysis.<xref ref-type="bibr" rid="article-140582.r5">[5]</xref> Most of the enzymes found in the liver are glucokinases rather than hexokinases; they do not catalyze the phosphorylation of fructose. In contrast to the hexokinase pathway, fructose is metabolized in the liver by the fructose 1-phosphate pathway.<xref ref-type="bibr" rid="article-140582.r6">[6]</xref></p>
      </sec>
      <sec id="article-140582.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Excess fructose consumption increasingly influences the global epidemics of diabetes mellitus, obesity, and the associated cardiometabolic risks.<xref ref-type="bibr" rid="article-140582.r7">[7]</xref> Moreover, the unique metabolic properties of fructose potentiate profound metabolic consequences like hypercholesterolemia, hypertriglyceridemia, and hyperuricemia.<xref ref-type="bibr" rid="article-140582.r8">[8]</xref></p>
      </sec>
      <sec id="article-140582.s4" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>The majority of cells are incapable of metabolizing fructose directly. Instead, all the reactions involved in fructose metabolism occur in the cytosol of cells, liver, muscle, adipose tissue, gut, and sperm.<xref ref-type="bibr" rid="article-140582.r9">[9]</xref></p>
      </sec>
      <sec id="article-140582.s5" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>
<bold>Absorption</bold>
</p>
        <p>The majority of ingested fructose is absorbed passively via glucose transporter 5 (GLUT5), also known as solute carrier family 2 facilitated glucose transporter member 5 (SLC2A5), which has a high binding affinity for fructose with a Km of 6 mM. Then GLUT 2 or SLC2A2 transports it into the bloodstream. The transport rate of fructose and intestinal GLUT5 mRNA levels is deficient during gestation. It rapidly increases after weaning regardless of diet, but they are further enhanced by introducing fructose-rich diets. In addition, high-fructose food enhances the thioredoxin interacting protein (TXNIP) in the intestine, which binds and regulates GLUT5-mediated fructose transport in the intestine. A carbohydrate-responsive element-binding protein (ChREBP) transcription factor regulates GLUT5 and TXNIP expression, which is necessary for systemic fructose tolerance.<xref ref-type="bibr" rid="article-140582.r10">[10]</xref></p>
        <p>
<bold>Proper Metabolic Pathway</bold>
</p>
        <p>
<bold>Adipose tissue and muscle</bold>
</p>
        <p>In adipose tissue and muscle, hexokinase phosphorylates fructose to synthesize fructose 6-phosphate, which then enters into glycolysis. Hexokinase, on the other hand, phosphorylates the majority of hexoses, including glucose. Furthermore, the Km of hexokinase for fructose is exponentially higher than that of glucose. Therefore, as glucose is a more favorable substrate for hexokinase, it competitively inhibits fructose phosphorylation by hexokinase.<xref ref-type="bibr" rid="article-140582.r11">[11]</xref></p>
        <p>
<bold>Liver, kidney, and intestine</bold>
</p>
        <p>In the liver, kidney, and intestine, fructokinase (or ketohexokinase) phosphorylates fructose at&#x000a0;the first carbon position to synthesize fructose 1-phosphate. Thus, most fructose is incorporated into the metabolic pathway through the fructokinase-catalyzed reaction, as glucokinase has poor substrate specificity for fructose. Fructokinase occurs in two different isoforms, isoform A and isoform C. In addition to having a ubiquitous tissue distribution, Isoform A has a lower affinity for fructose, which seems to diminish the amount of fructose available for metabolism by the liver. However, Isoform C is mainly present in the liver, intestine, and kidney and has a high affinity for fructose, leading to the rapid incorporation of fructose for metabolism. Then, fructose 1-phosphate aldolase or aldolase B degrades fructose 1-phosphate into dihydroxyacetone phosphate and glyceraldehyde. Finally, dihydroxyacetone phosphate enters glycolysis via triosephosphate isomerase, while triose kinase phosphorylates glyceraldehyde to form glyceraldehyde 3-phosphate. Thus, these&#x000a0;2 triose phosphates degrade by glycolysis or serve as a substrate for gluconeogenesis, the final fate of a considerable proportion of fructose metabolism in the liver.<xref ref-type="bibr" rid="article-140582.r12">[12]</xref></p>
        <p>
<bold>Polyol pathway</bold>
</p>
        <p>In the polyol pathway, glucose converts into sorbitol by aldolase reductase. Sorbitol further oxidizes into fructose by sorbitol dehydrogenase, accounting for fructose's appearance in seminal plasma. A seminal vesicle, hepatocytes, and ovarian cells express aldose reductase and sorbitol dehydrogenase, which synthesize fructose from glucose.<xref ref-type="bibr" rid="article-140582.r13">[13]</xref><xref ref-type="bibr" rid="article-140582.r14">[14]</xref></p>
        <p>
<bold>Regulation&#x000a0;</bold>
<xref ref-type="bibr" rid="article-140582.r15">[15]</xref>
</p>
        <p>
<bold>Regulation of fructose metabolism in the liver</bold>
</p>
        <p>The processing of fructose in the liver is not controlled by hormone or allosteric mechanisms, and fructose bypasses the rate-limiting step of glycolysis catalyzed by phosphofructokinase 1 (PFK 1). Hence, fructose metabolism is less tightly regulated and occurs at a much faster rate than glucose. Furthermore, aldolase-B performs a lysis step distinct from aldolase in glycolysis, producing dihydroxyacetone phosphate and glyceraldehyde due to its activity. In contrast to aldolase products, the latter must be phosphorylated to function.</p>
        <p>
<bold>Regulation at fructose uptake and phosphorylation</bold>
</p>
        <p>Fructose 1-phosphate acts as a positive allosteric modulator of glucokinase. The possible allosteric activity and high Km of glucokinase are due to the attachment of inhibitory glucokinase-regulatory protein inside the nucleus, which decreases the affinity of glucokinase for fructose. The translocation of the glucokinase-regulatory protein complex to the nucleus results in the inhibition of glucokinase activity. To relieve this inhibition, fructose-1-phosphate binds to the glucokinase-regulatory protein and stabilizes the dissociated protein. Insulin and postprandial glucose stimulate the dissociation of glucokinase-regulatory protein and transport it from the nucleus. Fructose phosphorylation is predominantly dependent on fructose concentration in tissues such as the liver, and a rise in fructose concentration leads to a decrease in cellular ATP.</p>
        <p>Metabolites of fructose enter the triose phosphate pool distal to PFK 1, bypassing the PFK 1 regulatory step. Thus, fructose loads can cause significant, rapid augmentations in the triose and hexose phosphate pools, potentially providing more substrate for all central carbon metabolic pathways, such as glycolysis, gluconeogenesis, glycogenesis, oxidative phosphorylation, and lipogenesis, because hepatic fructolysis is unrestricted.</p>
        <p>
<bold>Comparison of Fructolysis and Glycolysis&#x000a0;</bold>
<xref ref-type="bibr" rid="article-140582.r16">[16]</xref>
</p>
        <table-wrap id="article-140582.table0" position="float" orientation="portrait">
          <table style="height: 390px; width: 491px; float: left;" border="1" cellspacing="1" cellpadding="0">
            <tbody>
              <tr style="height: 4px;">
                <td style="width: 254.509px; height: 4px; text-align: center;" rowspan="1" colspan="1">
<bold>Fructolysis</bold>
</td>
                <td style="width: 190.491px; height: 4px; text-align: center;" rowspan="1" colspan="1">
<bold>Glycolysis&#x000a0;</bold>
</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 254.509px; height: 13px; text-align: left;" rowspan="1" colspan="1">Predominantly occurs in the liver&#x000a0;</td>
                <td style="width: 190.491px; height: 13px; text-align: left;" rowspan="1" colspan="1">Occurs in all tissues&#x000a0;</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 254.509px; height: 13px; text-align: left;" rowspan="1" colspan="1">Fructokinase entraps fructose inside hepatocytes. Its very high activity leads to the accumulation of fructose-1 phosphate. Fructokinase uses one ATP and converts it into AMP and Pi. Excessive fructose use causes rapid ATP utilization.</td>
                <td style="width: 190.491px; height: 13px; text-align: left;" rowspan="1" colspan="1">Hexokinase/glucokinase entraps glucose inside cells.</td>
              </tr>
              <tr style="height: 7.71436px;">
                <td style="width: 254.509px; height: 7.71436px; text-align: left;" rowspan="1" colspan="1">Fructolysis is less tightly regulated as it bypasses the PFK 1 step.</td>
                <td style="width: 190.491px; height: 7.71436px; text-align: left;" rowspan="1" colspan="1">Glycolysis regulation occurs at the PFK 1 step.</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 254.509px; height: 13px; text-align: left;" rowspan="1" colspan="1">
<p>Metabolic changes during the fructose-based diet:</p>
<p>Pyruvate, acetyl CoA, ATP, and citrate are not feedback inhibitors, so all fructose molecules metabolize through glycolysis only.&#x000a0;</p>
<p>Excess pyruvate directs to metabolic pathways such as fatty acid synthesis, cholesterol, and low-density lipoprotein (VLDL) synthesis. In addition, fructose activates a hepatic transcription factor, ChREBP, which upregulates acetyl CoA carboxylase and fatty acid synthase in the liver.</p>
<p>Additionally, excess fructose leads to hyperuricemia, as metabolism uses inorganic phosphate to make fructose 1-phosphate. The depleted inorganic phosphate decreases cellular ATP. As ATP falls, AMP rises. Further degradation of AMP produces hyperuricemia and lactic acidosis.&#x000a0;</p>
<p>Glycerol 3-phosphate dehydrogenase converts dihydroxyacetone phosphate into glycerol 3-phosphate, which also enters gluconeogenesis and synthesizes glucose.</p>
<p>Thus, a person on a high fructose diet produces hypercholesterolemia, hypertriglyceridemia, hyperuricemia, and hyperglycemia. In addition, consumption of a high fructose diet correlates with obesity, metabolic syndrome, gout, and diabetes mellitus.</p>
</td>
                <td style="width: 190.491px; height: 13px; vertical-align: top; text-align: left;" rowspan="1" colspan="1">
<p>Metabolic changes during the glucose-based diet:</p>
<p>Glucose enters glycolysis and produces pyruvate, acetyl CoA, citrate, and ATP, which inhibit PFK 1 by feedback inhibition and divert excess glucose toward alternative pathways like glycogen synthesis.</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-140582.s6" sec-type="Function">
        <title>Function</title>
        <p>Fructose promotes the uptake and storage of glucose in the liver. Fructose also helps to speed up the oxidation of carbohydrate stores after a meal.<xref ref-type="bibr" rid="article-140582.r17">[17]</xref></p>
        <p>Fructose provides the majority of the energy required for the mobility of spermatozoa. Seminal vesicles are responsible for the secretion of fructose. However, some people experience azoospermia due to a blockage in the duct of seminal vesicles. In such individuals, semen is analyzed for fructose concentration. Depending on whether fructose is present, the block will be above the seminal vesicular duct, and if it is absent, the block will be below the seminal vesicles.<xref ref-type="bibr" rid="article-140582.r18">[18]</xref></p>
        <p>Fructose may play a vital role in the maturation of preadipocytes, allowing them to store more fat.<xref ref-type="bibr" rid="article-140582.r19">[19]</xref>&#x000a0;Fructose may also benefit individuals in strenuous physical activity by sustaining hepatic gluconeogenesis and providing additional energy to contract skeletal muscle in lactate.<xref ref-type="bibr" rid="article-140582.r20">[20]</xref></p>
      </sec>
      <sec id="article-140582.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Hereditary Fructose Intolerance </bold>
</p>
        <p>hereditary fructose intolerance, or hereditary fructosemia, is an autosomal recessive inborn fructose metabolism error due to the aldolase B deficiency (mutation in <italic toggle="yes">ALDOB</italic> gene) or fructose 1,6-bisphosphate aldolase in the liver, intestine, and kidney. Affected infants are primarily asymptomatic until they consume fructose or sucrose through their diet (fruits, table sugar, honey) around weaning. After consuming fructose, fructose 1-phosphate builds up in the liver and kidney and causes toxic symptoms. In addition, fructose 1-phosphate inhibits fructokinase and decreases hepatic uptake of fructose, resulting in fructosemia. It is characterized by nausea, vomiting, abdominal pain, jaundice, hepatomegaly, and metabolic abnormalities such as hypoglycemia, hyperuricemia, hypermagnesemia, and hypophosphatemia.</p>
        <p>
<bold>Biochemical basis of hypoglycemia</bold>
</p>
        <p>Fructose converts into fructose 1-phosphate and gets trapped inside the hepatocytes. This leads&#x000a0;to depletion of inorganic phosphate, impairment of ATP synthesis and lack of cellular ATP, impairment in gluconeogenesis, and finally, hypoglycemia. In addition, fructose 1-phosphate allosterically inhibits hepatic glycogen phosphorylase, leading to postprandial hypoglycemia and glycogen accumulation in the liver.</p>
        <p>
<bold>Biochemical basis of liver and kidney dysfunction</bold>
</p>
        <p>Liver mitochondria cannot perform oxidative phosphorylation as sequestration of inorganic phosphate in the form of fructose 1-phosphate. The ATP levels plummet, making it impossible for the liver to perform normal work functions. In addition, the ATP-dependent cation pumps fail to maintain normal ion gradients, causing cell damage by osmotic lysis.</p>
        <p>Aldolase B is the predominant form of aldolase in proximal renal tubules. The interaction between aldolase B and vacuolar type-ATPase (V-ATPase) is critical for the proximal renal tubules for proper acidification function regarding proton transport across the tubules and endosomal acidification. Thus, the absence of V-ATPase-aldolase B interaction may contribute to renal tubular dysfunction in aldolase B deficiency.</p>
        <p>Impairment in protein synthesis, hyperuricemia, and magnesium release may be responsible for liver and kidney dysfunction. In addition, fructose 1-phosphate is a potent competitive inhibitor of phosphomannone isomer, an enzyme involved in the first step of protein N-glycosylation. Thus, defective N-glycosylation leads to improper protein synthesis, folding, and trafficking.</p>
        <p>Urine is positive for the reducing sugars test but negative for the glucose dipstick test. An aldolase B enzyme assay in a liver biopsy and DNA profiling by allele-specific probes serve as confirmatory diagnostic tests. In addition, monitoring increased carbohydrate-deficient transferrin by transferrin isoelectric focusing and increased activity of aspartylglucosaminidase should be used for disease follow-up to assess compliance with dietary restrictions.</p>
        <p>An early diagnosis of fructose intolerance and the prompt implementation of dietary measures to combat fructose intolerance is critical. Therefore, the primary strategy of therapy is to eliminate dietary fructose, sucrose, and sorbitol. Using fructose-containing intravenous fluids, medications, or infant formulas is not recommended during hospitalization. A sugar-free, water-soluble multivitamin is prescribed daily to prevent micronutrient deficiencies.<xref ref-type="bibr" rid="article-140582.r21">[21]</xref><xref ref-type="bibr" rid="article-140582.r22">[22]</xref></p>
        <p>
<bold>Essential Fructosuria&#x000a0;</bold>
</p>
        <p>Essential fructosuria, or benign fructosuria,&#x000a0;is an autosomal recessive disorder due to a deficiency of fructokinase that converts fructose into fructose 1-phosphate. Hepatocytes cannot trap fructose in the form of fructose 1-phosphate, which leads to the accumulation of fructose in the blood, and excess fructose readily excretes in the urine because fructose has a low renal threshold. It is not called fructosemia because hexokinase in extra-hepatic tissue metabolizes increased fructose levels in the blood. As a result, the level of fructose in the blood is not consistently elevated. It is an entirely benign condition without any symptoms or complications. It is diagnosed accidentally during urine examination, positive for reducing sugar and negative for glucose dipstick test. Urine chromatography for fructose serves as a confirmatory test to diagnose benign fructosuria. There is no need for any treatment or dietary restriction.<xref ref-type="bibr" rid="article-140582.r23">[23]</xref></p>
        <p>Increased fructose levels are associated with myocardial infarction and aging.&#x000a0;Fructose glycates at a rate tenfold that of glucose, and reduced antioxidant activity contributes to myocardial infarction.<xref ref-type="bibr" rid="article-140582.r24">[24]</xref><xref ref-type="bibr" rid="article-140582.r25">[25]</xref></p>
      </sec>
      <sec id="article-140582.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140582&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140582">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140582/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140582">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140582.s9">
        <fig id="article-140582.image.f1" position="float" orientation="portrait">
          <caption>
            <p>The Metabolic Pathway of Fructose Contributed by&#x000a0;M Radadiya, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Pathway__of__Fructose__Metabolism" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140582.s10">
        <title>References</title>
        <ref id="article-140582.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sloboda</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Clayton</surname>
                <given-names>ZE</given-names>
              </name>
              <name>
                <surname>Yap</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vickers</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Early life exposure to fructose and offspring phenotype: implications for long term metabolic homeostasis.</article-title>
            <source>J Obes</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>203474</fpage>
            <pub-id pub-id-type="pmid">24864200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Empie</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Fructose metabolism in humans - what isotopic tracer studies tell us.</article-title>
            <source>Nutr Metab (Lond)</source>
            <year>2012</year>
            <month>Oct</month>
            <day>02</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <pub-id pub-id-type="pmid">23031075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theytaz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Giorgi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hodson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stefanoni</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rey</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schneiter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Giusti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tappy</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Metabolic fate of fructose ingested with and without glucose in a mixed meal.</article-title>
            <source>Nutrients</source>
            <year>2014</year>
            <month>Jul</month>
            <day>15</day>
            <volume>6</volume>
            <issue>7</issue>
            <fpage>2632</fpage>
            <page-range>2632-49</page-range>
            <pub-id pub-id-type="pmid">25029210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Samuel</surname>
                <given-names>VT</given-names>
              </name>
            </person-group>
            <article-title>The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis.</article-title>
            <source>Trends Endocrinol Metab</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>719</fpage>
            <page-range>719-730</page-range>
            <pub-id pub-id-type="pmid">27387598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Legeza</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marcolongo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gamberucci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>B&#x000e1;nhegyi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Benedetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Odermatt</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome.</article-title>
            <source>Nutrients</source>
            <year>2017</year>
            <month>Apr</month>
            <day>26</day>
            <volume>9</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">28445389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hannou</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Haslam</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>McKeown</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Herman</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Fructose metabolism and metabolic disease.</article-title>
            <source>J Clin Invest</source>
            <year>2018</year>
            <month>Feb</month>
            <day>01</day>
            <volume>128</volume>
            <issue>2</issue>
            <fpage>545</fpage>
            <page-range>545-555</page-range>
            <pub-id pub-id-type="pmid">29388924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pollock</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Bundy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kanto</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gutin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents.</article-title>
            <source>J Nutr</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>142</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-7</page-range>
            <pub-id pub-id-type="pmid">22190023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000ea;</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Tappy</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Metabolic effects of fructose.</article-title>
            <source>Curr Opin Clin Nutr Metab Care</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>469</fpage>
            <page-range>469-75</page-range>
            <pub-id pub-id-type="pmid">16778579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalez</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Betts</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Dietary Fructose Metabolism By Splanchnic Organs: Size Matters.</article-title>
            <source>Cell Metab</source>
            <year>2018</year>
            <month>Mar</month>
            <day>06</day>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>483</fpage>
            <page-range>483-485</page-range>
            <pub-id pub-id-type="pmid">29514059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferraris</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Choe</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Intestinal Absorption of Fructose.</article-title>
            <source>Annu Rev Nutr</source>
            <year>2018</year>
            <month>Aug</month>
            <day>21</day>
            <volume>38</volume>
            <fpage>41</fpage>
            <page-range>41-67</page-range>
            <pub-id pub-id-type="pmid">29751733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Boros</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Nolen</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wabitsch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beger</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Kaput</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Metabolic fate of fructose in human adipocytes: a targeted <sup>13</sup>C tracer fate association study.</article-title>
            <source>Metabolomics</source>
            <year>2015</year>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>529</fpage>
            <page-range>529-544</page-range>
            <pub-id pub-id-type="pmid">25972768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akram</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hamid</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mini review on fructose metabolism.</article-title>
            <source>Obes Res Clin Pract</source>
            <year>2013</year>
            <season>Mar-Apr</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>e89</fpage>
            <page-range>e89-e94</page-range>
            <pub-id pub-id-type="pmid">24331770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frenette</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thabet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Polyol pathway in human epididymis and semen.</article-title>
            <source>J Androl</source>
            <year>2006</year>
            <season>Mar-Apr</season>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>233</fpage>
            <page-range>233-9</page-range>
            <pub-id pub-id-type="pmid">16278369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Hwa</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Aldose reductase, oxidative stress, and diabetic mellitus.</article-title>
            <source>Front Pharmacol</source>
            <year>2012</year>
            <volume>3</volume>
            <fpage>87</fpage>
            <pub-id pub-id-type="pmid">22582044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feinman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Fructose in perspective.</article-title>
            <source>Nutr Metab (Lond)</source>
            <year>2013</year>
            <month>Jul</month>
            <day>01</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <pub-id pub-id-type="pmid">23815799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sievenpiper</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Cozma</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Chiavaroli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mirrahimi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fructose vs. glucose and metabolism: do the metabolic differences matter?</article-title>
            <source>Curr Opin Lipidol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-19</page-range>
            <pub-id pub-id-type="pmid">24370846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laughlin</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Normal roles for dietary fructose in carbohydrate metabolism.</article-title>
            <source>Nutrients</source>
            <year>2014</year>
            <month>Aug</month>
            <day>05</day>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>3117</fpage>
            <page-range>3117-29</page-range>
            <pub-id pub-id-type="pmid">25100436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sabanegh</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Obstructive azoospermia: reconstructive techniques and results.</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2013</year>
            <volume>68 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>61</fpage>
            <page-range>61-73</page-range>
            <pub-id pub-id-type="pmid">23503955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Du</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Heaney</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Regulation of adipose differentiation by fructose and GluT5.</article-title>
            <source>Mol Endocrinol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>10</issue>
            <fpage>1773</fpage>
            <page-range>1773-82</page-range>
            <pub-id pub-id-type="pmid">22827929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuchs</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>van Loon</surname>
                <given-names>LJC</given-names>
              </name>
            </person-group>
            <article-title>Fructose co-ingestion to increase carbohydrate availability in athletes.</article-title>
            <source>J Physiol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>597</volume>
            <issue>14</issue>
            <fpage>3549</fpage>
            <page-range>3549-3560</page-range>
            <pub-id pub-id-type="pmid">31166604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Seong</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Hereditary Fructose Intolerance Diagnosed in Adulthood.</article-title>
            <source>Gut Liver</source>
            <year>2021</year>
            <month>Jan</month>
            <day>15</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>142</fpage>
            <page-range>142-145</page-range>
            <pub-id pub-id-type="pmid">33028743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ammar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ives</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Albrecht</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gluck</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Physical interaction between aldolase and vacuolar H+-ATPase is essential for the assembly and activity of the proton pump.</article-title>
            <source>J Biol Chem</source>
            <year>2007</year>
            <month>Aug</month>
            <day>24</day>
            <volume>282</volume>
            <issue>34</issue>
            <fpage>24495</fpage>
            <page-range>24495-503</page-range>
            <pub-id pub-id-type="pmid">17576770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Inborn Errors of Fructose Metabolism. What Can We Learn from Them?</article-title>
            <source>Nutrients</source>
            <year>2017</year>
            <month>Apr</month>
            <day>03</day>
            <volume>9</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">28368361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malik</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Oct</month>
            <day>06</day>
            <volume>66</volume>
            <issue>14</issue>
            <fpage>1615</fpage>
            <page-range>1615-1624</page-range>
            <pub-id pub-id-type="pmid">26429086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140582.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaby</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Adverse effects of dietary fructose.</article-title>
            <source>Altern Med Rev</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>294</fpage>
            <page-range>294-306</page-range>
            <pub-id pub-id-type="pmid">16366738</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
